Lowest Price Guaranteed
Slides
237
Last Updated
September 2025
View Count
9683
The global companion animal health market size, valued at USD 24.50 billion in 2024, is projected to reach USD 26.53 billion in 2025 and USD 51.45 billion by 2035, representing a CAGR of 6.8% during the forecast period.
 |
To learn more about this report, request a free sample copy
With growing pet ownership and rising awareness of zoonotic diseases, the companion animal health market has grown exponentially. Over the years, animals such as dogs and cats have shown a significant companionship with humans for emotional and entertainment support. Given the growing companionship, pet owners now treat their companion animals as important and are willing to make considerable investment for pet health.
Additionally, the zoonotic diseases (disease that transmit from animals to humans) have caught the attention of pet owners and veterinarians, which has necessitated the requirement of advanced diagnostics techniques, treatments (based on animal genetics) and nutritional feed to maintain good health of companion animals. Besides this, animal health organizations globally are focusing on preventive measures and treatment modalities for animals suffering from canine influenza, chronic diseases and cancer, which has further catalyzed the requirement of companion animal health products.
Considering the ongoing focus on pet health, various industrial players active in this field are taking strategic initiatives to evolve new diagnostic technologies and pharmaceutical products. The industry is further backed by scientific research to mitigate the growing concern of infectious diseases in animals. For instance, in April 2024, European Commission announced the European Partnership for Animal Health and Welfare. Under this partnership 56 European research institutes and 30 funding organizations along with Austrian Science Fund teamed up to combat the risk of infectious diseases in animals. European Commission is expected to invest over €360 million over seven years to facilitate research and innovation in this field.
These collective efforts have caught the attention of industrial players to take strategic initiatives for delivering optimal care solutions. Given by the rising initiatives, we believe the market to remain competitive and investible for the long term, offering opportunities for industrial players to drive innovations.
The research report provides valuable information on leading industrial players who are presently active across various segments of the companion animal health industry.
| Key Report Attributes | Details | |
| Historical Trend | Since 2019 | |
| Forecast Period | Till 2035 | |
| Current Market Size | $ 26.53 Billion | |
| Market Size 2035 | $ 51.45 Billion | |
| CAGR (Till 2035) | 6.8% | |
| Type of Animal |
|
|
| Type of Product |
|
|
| Type of Health Concern |
|
|
| Distribution Channel |
|
|
| End User |
|
|
| Geographical Regions |
|
|
| Key Companies Profiled |
|
|
| PowerPoint Presentation (Complimentary) |
Available | |
| Customization Scope | 15% Free Customization | |
| Excel Data Packs (Complimentary) |
Available | |
One of the key objectives of the market report was to estimate the current companion animal health market size, opportunity and the market growth potential, over the forecast period, till 2035. We have provided informed estimates on the likely evolution of the market for the forecast period.
The companion animal health market analysis also features the likely distribution of the current and forecasted opportunity within the market across various segments, such as type of animal (dogs, cats, avian, equine and other animals), type of product (pharmaceuticals (drugs (anti-parasitic, anti-infectives, anti-inflammatory and other drugs), vaccines (modified live vaccines, killed inactivated vaccines and other vaccines), medicated feed additives (antibiotics, vitamins, enzymes, amino acids, antioxidants, prebiotics and probiotics, minerals and other medicated feed additives)), medical devices (veterinary diagnostic equipment, veterinary anesthesia equipment, veterinary patient monitoring equipment, veterinary surgical equipment, veterinary consumables and other medical devices), diagnostics (immunodiagnostic tests, molecular diagnostics, diagnostic imaging, and other diagnostics) and veterinary services), type of health concern (infectious diseases, chronic diseases, nutritional disorders and preventive care), distribution channel (hospital pharmacies, e-commerce and retailers), end user (veterinary hospitals & clinics, diagnostic laboratories, research institutes, home care settings, and other end users), geographical region (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America) and leading players.
In order to account for future uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base, and optimistic scenarios, representing different tracks of industry’s evolution.
All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. The financial figures mentioned in this market report are in USD, unless otherwise specified.
Based on the type of animal, the global companion animal health market size is segmented into dogs, cats, avian, equine and other animals. According to our projection, dogs account for the largest share (46 %) of the market. Dogs are the most common pets. According to 2024 APPA National Pet Owners Survey Stats, 58 million households in the US owned a dog, of the total 82 million households having a pet. Dogs show a strong emotional bond with humans and pet owners are increasingly investing in pet wellness products and healthcare. Moreover, dog owners are focusing on advanced treatments and preventive healthcare services, which has further fueled the growth of this segment.
It is important to highlight here that cat’s segment is anticipated to register a higher CAGR during the forecast period. This can be attributed to the growing demand for furry cats in urban settings. With rising adoption, cat owners are spending additional amount of regular health check-ups for disease management and infection control. Moreover, cat owners are also spending on specialized feed formulation to maintain good health of cats, which is anticipated to be a robust reason for growth.
This segment highlights the distribution of market size across different type of product, such as pharmaceuticals (drugs (anti-parasitic, anti-infectives, anti-inflammatory and other drugs), vaccines (modified live vaccines, killed inactivated vaccines and other vaccines), medicated feed additives (antibiotics, vitamins, enzymes, amino acids, antioxidants, prebiotics and probiotics, minerals and other medicated feed additives), medical devices (veterinary diagnostic equipment, veterinary anesthesia equipment, veterinary patient monitoring equipment, veterinary surgical equipment, veterinary consumables and other medical devices), diagnostics (immunodiagnostic tests, molecular diagnostics, diagnostic imaging, and other diagnostics) and veterinary services).
Among these, currently the pharmaceuticals market segment accounts for the highest companion animal health market share (42%). This is primarily due to the rising risk of infectious and chronic conditions in companion animals that necessitated the demand for advanced therapeutic drugs and diagnostic techniques for treating animals. It is important to highlight here that vaccines also hold a substantial share of the market owing to the growing focus on veterinary vaccines to prevent the risk of infectious diseases in animals.
However, in the long run, the veterinary services segment is expected to grow at a higher CAGR during the forecast period. This can be attributed to the rising expenditure on pets for preventive care, treatment, diagnostics, dental care and emergency veterinary services. Veterinary services cover regular checkups, grooming and daily care services, which have been adopted on a large scape by companion animal owners to maintain overall wellbeing of their pet.
On the basis of health concern type, the global companion animal health market is distributed into infectious diseases, chronic diseases, nutritional disorders and preventive care. Currently, infectious diseases account for the highest share of the market. This can be attributed to the growing concern of zoonotic and infectious diseases across animals. However, in the long run, nutritional disorders segment is likely to grow at a higher CAGR during the forecast period. This is due to the growing awareness among pet owners about nutritional value in maintaining the overall well-being of the pet.
The global market is distributed across different types of distribution channels, such as hospital pharmacies, e-commerce and retailers. Currently, hospital pharmacies segment occupies the highest companion animal health market share (47%). This can be attributed to the availability of a wide range of pharmaceutical products in hospital pharmacies that are specifically tailored for treatment. Furthermore, the availability of healthcare professionals for pharmaceutical product recommendation and treatment guidance has further contributed to the highest share of this segment.
However, in the long run, e-Commerce segment is likely to grow at a higher CAGR during the forecast period. This lucrative growth is due to the convenience of purchasing and availability of a wide range of pet healthcare and feed formulas on e-Commerce sites. Furthermore, e-Commerce platforms offer cost-effective products, which further fueled the growth of this segment during the projected period.
Based on the end user, the global companion animal health market size is segmented into veterinary hospitals & clinics, diagnostic laboratories, research institutes, home care settings, and other end users. According to our projection, veterinary hospitals & clinics account for the highest share (over 80%) of the market. This can be attributed to the availability of advanced healthcare infrastructure, professional veterinarian and wide range of pharmaceutical products along with daily care services in hospital settings.
In the long run, home care settings segment is likely to register higher CAGR during the forecast period. This is likely to be the result of rising focus on point of care diagnostics and remote treatment facilities for maintaining health of companion animals.
The global companion animal health market is distributed across different geographical regions, such as North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America. According to our projection, North America currently occupies the highest share (39%) of the market. This can be attributed to the rising adoption of companion animals and high demand for advanced treatments to mitigate the growing concern of zoonotic diseases in this region. Furthermore, there has been an increase in the adoption of pet health insurance in North America. As per North American Pet Health Insurance Association state of the industry report 2024, there were nearly 5.6 million insured pets in the US in 2023. These included more than 4.4 million dogs and 1.2 million cats. Pet insurance helps meet the rising medical expenditures.
Europe also holds significant share of the market, with the region being home to around 352 million pets in 2022, as published by European Pet Food Industry (FEDIAF). Cats are the most common pets, closely followed by dogs. In certain countries of the region, pet insurance is also widely accepted. Sweden and UK lead the pet insurance adoption rates at 80% and 30% of the pet population being covered in these countries, respectively.
In Asia-Pacific, the market for companion animal health is expected to witness substantial growth, expecting to grow at the fastest CAGR during the forecast period. The market in this region has been fueled by the rising government initiatives to support animal health and growing pet ownership in this region. Furthermore, various industrial players are focusing on developing innovative vaccines at affordable rate to enhance the adoption of vaccinations for pet, which in turn anticipated to fuel the market growth in this region.
The “Companion Animal Health Market: Industry Trends and Global Forecasts, till 2035” research report features an extensive study of the focus on competitive landscape of strategic initiatives, emerging mega trends, big pharma initiatives, company profiles and key drivers and restraints. The market report highlights the efforts of several stakeholders engaged in this rapidly evolving segment of the animal health industry. Key takeaways of the market data analysis are briefly discussed below.
Currently, the market landscape of companion animal health is moderately competitive, witnessing the presence of several small, mid-sized and large companies. Key players of the industry are focusing on the development of advanced therapies and diagnostics technologies to offer personalized preventive care to the companion animals.
In order to leverage the competitive edge, several industrial players have entered into strategic partnerships and collaborations aiming to expand product portfolio. For instance, in August 2024, Amferia (Swedish medtech company) announced about forging second commercial agreement with Biokema (Swiss animal health company) for commercialization of proprietary wound care technology of Amferia for animal health in Switzerland.
As more market players continue to focus on innovations in this field, the market will remain competitive throughout the projected period.
Human companionship with animals has played a significant role in driving the market. With rising adoption of pets such as dogs and cats for emotional bonding, pet owners are increasingly focused on the wellbeing of their animals. Driven by the growing spending on health, there has been a surge in the demand for animal nutrition products, therapeutic products and services. Furthermore, the increasing disposable income and rising pet health insurance facilities has further bolstered the market growth during the forecast period. In addition, growing concern of zoonotic diseases has further fueled the demand for companion animal health products and services.
Some of the challenges in companion animal health market that may limit the adoption of veterinary services include high treatment cost and inconsistency in accessing healthcare facilities. Furthermore, regulatory complexities associated with the approval of therapeutic products may hinder market progress during the forecast period. Additionally, lack of reimbursement policies for animals specifically in low- and middle-income countries may limit the adoption of veterinary healthcare services to maintain good health of pets.
Companion animal health industry is witnessing a transformative shift driven by technological advancements and drug innovations. Some of the potential companion animal health market growth factors included wearable technologies, functional feed products and advancements in veterinary care. It is important to highlight that functional feed products with high nutritional additives play a significant role in maintaining optimal health. In addition, probiotics, phytogenic nucleotide and prebiotics have been adopted for animal health by pet owners.
Furthermore, industrial players are focusing on integrating wearable technologies and artificial intelligence for real-time monitoring of diseases. Pet wearable technologies is another significant trend of the companion animal health industry that aims to track health remotely. In January 2025, STELLAI launched a dog tracker and smart collar that is also equipped with several sensors to monitor pet health. Furthermore, AI has also found its application in veterinary diagnostics and is proving time and cost saving for the pet owners as well as veterinary practices. As stated by Dr David White, clinical director at Royston Veterinary Clinic “AI means I can diagnose and treat with confidence and so it's no more expensive to the pet owner because we're more likely to get it right first time."
Currently, the global market for companion animal health is valued at USD 26.53 billion and is poised to reach USD 51.45 billion by 2035. Driven by the rising adoption of pets and growing spending on animal health by owners, the market is likely to expand at a CAGR of 6.8% during the forecast period.
It is important to highlight here that technological innovations and advanced therapeutics will remain the cornerstone of companion animal health industry. For instance, in June 2024, Merck Animal Health (Division of Merck) announced that U.S Department of Agriculture has approved NOBIVAC® NXT Canine Flu H3N2 (next generation solution) for safeguarding dogs against canine influenza. Similar to canine influenza therapies, the industrial players are focusing on the development of novel vaccine and therapeutics to treat canine cancer. Owing to the ongoing approval and advancements in this field, the companion animal health market is likely to remain competitive during the forecast period.
Examples of key players engaged in this field of companion animal health (which have also been captured in this report) include Agrolabo, Boehringer Ingelheim International, Bayer, Ceva Animal Health, Dechra Pharmaceuticals, Elanco Animal Health, Heska, IDEXX Laboratories, Merck, Neogen, Norbrook, Ourofino Saúde Animal, Phibro Animal Health, Virbac, Vetoquinol and Zoetis. This market report includes an easily searchable excel database of all the companies focusing on companion animal health products.
The market report presents an in-depth analysis, highlighting the capabilities of various companies engaged in this domain across different segments. Amongst other elements, the market report includes:
Several recent developments have taken place in the field of companion animal health. We have outlined some of these recent initiatives below.